Heritage Study

Heritage Study

Investigating the immune kinetics of COVID-19 vaccine responses between European and African populations

The purpose of this study is to understand immune response to the COVID-19 vaccine. This research study is led by Yemaachi Biotech Ltd, in partnership with Ghana Health Service, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Francis Crick Institute, and Bill & Melinda Gates Foundation.

You may participate in this study if you:

  • Are 18 years or older
  • have not yet been vaccinated for COVID-19

Participation consists of 7 visits* to your vaccination site over 12 months, which would involve:

  • COVID-19 testing
  • 2 doses of AstraZeneca or Pfizer COVID-19 vaccine
  • Blood sample collection
  • Answering questions about your experiences following your COVID-19 vaccinations.